One Veteran-One Standard - Guiding Principles > Medical Marihuana - marihuana à des fins médicales

List of Dr who will approve medical marihuana: NB, NS, PEI, BC, AB, Ont, MN, ME

(1/2) > >>

Sylvain Chartrand CD:
Credit for this list goes to Ian Bailey NOT HIM IN THE PHOTO


      Dr Colleen O'Connell (Referrals only)Specialist

      (506) 447-4294

      (506) 452-5681

      Stan Cassidy Rehab Centre,

      Fredericton, NB

      She specializes in spinal cord, head and neurological injuries.


      Dr Paul Smith

      640 Prospect

      Fredericton, NB

      E3B 9M7

      (506) 455-2900

      (506) 784-6300


      Dr Douglas D Smith(Referrals only)Specialist

      139 Brunswick Street

      Fredericton, NB

      E3B 1G7

      (506) 450-3321

      Pain Specialist

      Physical Medicine


      Dr. David Bell M.D

      500 East Riverside Dr

      Perth-Andover NB,

      E7H 1Z1

      Phone #: 506-273-3558

      506-273-9560 Fax #: 506-273-9560


      Dr Gary Baker???

      New Maryland walk-in clinic After Hours Medical Clinic

      636 New Maryland Hwy

      Fredericton, NB


      Phone: (506) 458-8927

      Monday – Friday:

      6 pm – 10 pm


     Dr. Douglas D. Smith

     (506) 450-3321

     fax (506) 450-3371


     Dr. John Keddy

     1015 Regent St,

     Fredericton, NB E3B 6H5

     (506) 458-0246




     Dr. Desmond Colohan

     Island Pain Management Clinic – Boardwalk Medical Centre

     220 Water Street

     Charlottetown, PE,

     C1A 9M5

     902-367-3344 (phone)

     902-367-4114 (fax)




      Dr Thomas Hydorn

      16 Church St

      PO Box 128 Stn Main

      Amherst, Nova Scotia

      B4H 3Y6


      General Practitioner


      Dr Campbell.

      North End Community Health Centre

      2165 Gottingen St.

      Halifax, Nova Scotia



      Dr Kevin Jay Kanerva

      Suite 421

      9-3151 Lake Shore Road

      Kelowna, BC

      Phone: (250) 860-3456

      Fax: (250) 764-1684


      Dr Kevin Jay Kanerva

      Preventive Medicine

      3 - 1745 Spall Rd.

      Kelowna BC,


      V1Y 4P7


      Phone (250) 212 4899

      Fax (250) 764 1684

      ( thats the private clinic which charges $2400 for a ANY SIZE exemption


      Dr Tersia Lichtenstein

      1605 Gordon Dr

      Kelowna , BC


      (250) 763-1183



     Dr Gouch

     Canada Ave Clinic in Duncan, B.C.

     250 597 1185


For b1. Peeps have to call in. get fax # and then fax med records in.  They screen the file to verify illness then the doctor will skype the appointment for anyone in canada




     Dr. Oliver

      Swan Hills AB




      Dr Mark Laurence Latowsky

      Suite 207

      3447 Kennedy Road

      Scarborough ON,

      M1V 3S1

      (416) 332-2757

      Fax #: 416-332-3747


      Dr David Saul

      Unit 201

      80 Finch Ave. W.

      Phone (416) 221 3633

      Fax (416) 221 5599


      Dr Geraint Lewis,

      1053 Carling,


      Ottawa, ON

      K1Y 4E9

      613-798-5555 ext. 14169

      Speciality ==Anaesthesia, and Chronic Pain management.


      Dr. Tsvi Gallant, G.P.

      Gallant Medical Clinic

      2797 Bathurst St,

      North York, ON M6B 4B9



     Dr. Rob Kamermans

      Coe Hill, ON



      Dr. Colin Kovacs, Maple Leaf Clinic

      70 Carlton ST


Dr. Colin Kovacs is a primary care physician currently practicing at the Maple Leaf Medical Clinic in Toronto. Colin has been in active full time HIV/AIDS clinical care since 1994 and has been inducted to the Ontario AIDS Network Honour Roll. He has been engaged in clinical and investigator driven research since the mid-1990's with collaborations throughout Canada and abroad including such agencies as the National Institutes of Health, Johns Hopkins University, and the University of Utretch.  Colin has been a past OHTN Board Member and active participant of the Emerging Technologies Working Group.


      Dr. John Goodhew  GP/HIV Primary Care group

      235 Danforth Ave, Ste. 406

      Toronto, ON M4K 1N2


      f. 416-463-6577



     Nayomi Lear


     2401 Yonge Street

     Toronto, ON



    London, ON

    (519) 667-6721


    Gordon Arbess

    410 Sherbourne Street

    Toronto, ON

    (416) 867-3728


    Dr Donal Kilby

    100 Marie Curie Pvt

    Ottawa, ON  K1N 1A2



   Dr Donal Kilby

   100 Marie Curie Pvt

   Ottawa, ON K1N 1A2




 Dr. Peter Blecher, M.D., C.M., DAAPM, DCAPM,

 Vital CME

   Director of Interventional Training for Centres for Pain Management

-->  This will require Administrator confirmation of allowance to post.





      Dr Dustin Sulak, D.O,

      47 Water Street

      Suite 104

      Hallowell, Maine


      (207) 512-8633 office


      * Doctor of Osteopathy - Licensed General Practitioner

      * Reiki Sensei

      * Certified Clinical Hypnotherapist

      * Certified BodyTalk Practitioner

      * Bachelor of Science in Biology

      * Bachelor of Science in Nutrition



      Dr. Woytowicz graduated with an MD 24 years ago and has a practice in Augusta,


      Family Medicine Institute

      15 East Chestnut Street

      Augusta, ME, 04330

      Phone Number:(207) 626-1894

Wife of a Veteran:
Thank You

Sylvain Chartrand CD:
Canada to Pay for Military Veterans Medical Marijuana

By Canadian Press - Friday, May 15 2009

    Medical Marijuana
    Veterans Affairs

The military may strictly forbid marijuana use by its soldiers, but the federal government has decided to pay for medical cannabis for some veterans.

Veterans Affairs has reversed a previous ban, now saying it "may provide payment in relation to the associated costs of medically required marijuana to clients who have qualified."

Payments can be made only to veterans licensed by Health Canada to possess medical marijuana, and who buy government-certified cannabis produced on contract by a firm in Flin Flon, Man.

The policy change was approved last October, but is only now being communicated to veterans who require the product for pain management and other severe medical conditions.

About eight veterans licensed by Health Canada are having their medical marijuana bills picked up by taxpayers, said Janice Summerby, spokeswoman for Veterans Affairs.

She was unable to say immediately how much the new policy was costing the department.

"These guys (the federal government) want to stand up for veterans' rights," said Bruce Webb, a Comox, B.C., veteran who successfully pressed Veterans Affairs Minister Greg Thompson for the about-face.

"They want to help."

Webb, a former air force corporal who received a medical discharge in 2002, said the new payment policy will cover the $490 monthly cannabis bill he faces while struggling on a disability pension.

He could not afford the cost of his daily three-gram marijuana medication, but now is renewing his expired Health Canada licence to take advantage of the payment program.

Webb, 46, said he learned of the change in a letter from Thompson last week, and is trying to get the word out to hundred of veterans he says could benefit.

Veterans Affairs has previously paid the costs of some synthetic forms of cannabis that have been certified as prescription drugs in Canada.

The Health Canada-approved marijuana, currently produced on contract by Prairie Plant Systems Inc., has been criticized as too weak and dry by some users.

But Webb praised the product, saying it makes an "amazing difference" in controlling pain caused by his sports injury from 1999.

Health Canada has been forced by a series of court decisions this decade to set up a program to license medical marijuana users, and to provide government-certified dope to users at a cost.

Patients have also been allowed to grow medical marijuana for themselves, or have someone else grow it for them under licence.

Health Canada, which eventually wants to phase out personal production, recently lost a court case over restrictions preventing licensed growers from serving more than one patient.

Sylvain Chartrand CD:
Health Canada plans to treat marijuana like other medicines

Individuals would no longer be permitted to grow their own
CBC News
Posted: Dec 16, 2012 5:08 PM ET

A proposal released by Health Canada would treat medical marijuana more like medicine and effectively commercialize its production and distribution.

"Current medical marijuana regulations have left the system open to abuse," Minister of Health Leona Aglukkaq stated in a press release on Sunday.

She said the proposed Marijuana for Medical Purposes Regulations (MMPR) would help control illegal activity, while also allowing easier access for those patients who have genuine medical needs.

In order to be approved for a license, producers must:

    * Employ a quality assurance person with appropriate training, experience and knowledge.
    * Have an indoor production site (not in a private residence).
    * Have restricted access to their production site.
    * Have a 24/7 camera security system and alarm system.
    * Hold valid security clearance, authorized by the Minister of Health.
    * Provide notification of their application and details about their site to local police, fire and government officials.

"These changes strike the right balance between patient access and public safety," she said

Essentially, the new system will create licensed grow-ops that people could shop at, provided they have a prescription from their doctor. The regulations would allow for a regulated commercial market of licensed producers.

Currently, those who wish to use medical marijuana must apply for a permit from the government in order to either grow it themselves or buy it from a single government grower.

Adam Greenblatt, executive director of the Montreal-based Medical Cannabis Society (MCAS), said his organization advised Health Canada on the new regulations last summer.

"Unfortunately, they didn't take all of our counsel, which would have resulted in a far more patient-friendly regime," he stated.

    'For many patients who grow their own [marijuana], this is one step forward and two steps back'
    —Adam Greenblatt, Medical Cannabis Society

Among its proposals, the MMPR suggests the price of medical marijuana should rise to $8.80 per gram. It currently it ranges from $1.80 to $5 per gram.

The regulation also says it would no longer permit individuals to grow their own marijuana, a move that Greenblatt says is unfair.

"For many patients who grow their own, this is one step forward and two steps back," he said.

Despite some issues, Greenblatt remained optimistic. He said the merging of a social justice movement with the commercial sector will undoubtedly be a "bumpy ride."

"Creating a commercial marketplace is ostensibly progressive," he added.
Highlights from the proposed regulations:

    * Elimination of production of marijuana by individuals in their homes.
    * An end to Health Canada's role in authorizing the production, possession, supplying and distributing of marijuana.
    * Establishment of a regulated commercial market for licensed producers.
    * Patients would no longer be required to apply to Health Canada and submit their personal medical information to the government.
    * Patients would obtain a medical document (similar to a prescription) and purchase marijuana directly from the producer.
    * Individuals would not be required to consult a specialist in addition to their normal health care practitioner.

The proposed regulations are expected to come into force in the spring.

Details of the new regulations will be available on Health Canada's website and the public can weigh in during a 75-day comment period, which ends on Feb. 28, 2013.

Sylvain Chartrand CD:
Harper Government Announces New Medical Marihuana Regulations

June 10, 2013 09:44 ET

OTTAWA, ONTARIO--(Marketwired - June 10, 2013) - Today, the Honourable Leona Aglukkaq, Minister of Health, announced new regulations that will change the way Canadians access marihuana for medical purposes. The new Marihuana for Medical Purposes Regulations (MMPR) will be published in the Canada Gazette, Part II, on June 19, 2013.

"While the courts have said that there must be reasonable access to a legal source of marihuana for medical purposes, we believe that this must be done in a controlled fashion in order to protect public safety," said Minister Aglukkaq. "These changes will strengthen the safety of Canadian communities, while making sure patients can access what they need to treat serious illnesses."

Since its introduction in 2001, Health Canada's Marihuana Medical Access Program (MMAP) has grown exponentially, from under 500 authorized persons to over 30,000 today. This rapid increase has had unintended consequences for public health, safety and security as a result of allowing individuals to produce marihuana in their homes. Under the new regulations, production will no longer take place in homes and municipal zoning laws will need to be respected, which will further enhance public safety.

The new Marihuana for Medical Purposes Regulations aim to treat marihuana as much as possible like other narcotics used for medical purposes. The regulations will provide access to quality-controlled marihuana for medical purposes, produced under secure and sanitary conditions, to those Canadians who need it.

The regulations will also streamline the process for applicants and health care practitioners. Under the new regime, individuals will not be required to provide personal medical information to Health Canada. Health care practitioners will be able to sign a medical document enabling patients to purchase the appropriate amount related to their conditions directly from a Licensed Producer approved by Health Canada.

In order to facilitate the transition from the current program to the new regime, both will operate concurrently until March 31, 2014. Effective April 1, 2014, Health Canada will no longer produce and distribute marihuana for medical purposes. The current Marihuana Medical Access Regulations (MMAR) will be repealed on March 31, 2014, when the new regime is fully implemented. Additional information on key dates will be provided to program participants and other stakeholders throughout the transition period.

For a copy of the new regulations in advance of the June 19 publication date, please email:

Également disponible en français

Health Canada news releases are available on the Internet at


Marihuana for Medical Purposes Regulations

New Marihuana for Medical Purposes Regulations (MMPR) will come into force in June 2013.

Following broad consultations with stakeholders, the Government of Canada was concerned that the Marihuana Medical Access Program (MMAP) was open to abuse.

The MMPR represent a comprehensive response to a number of concerns raised over the past years and during the public comment period following the introduction of the draft regulations in December 2012.

The regulations aim to treat marihuana as much as possible like any other narcotic used for medical purposes by creating conditions for a new, commercial industry that is responsible for its production and distribution. The regulations will provide access to quality-controlled marihuana for medical purposes, produced under secure and sanitary conditions, to those Canadians who need it, while strengthening the safety of Canadian communities. In addition, the new regulations will also provide more choices of marihuana strains and commercial suppliers.

Under the new regulations:

    the process for applicants and health care practitioners will be streamlined, eliminating the need for individuals to provide Health Canada with their personal information or apply to the department for an Authorization to Possess;
    personal and designated production by individuals in their homes will be eliminated on March 31, 2014;
    current options to access marihuana for medical purposes will be replaced by regulated, commercial Licensed Producers who will be able to produce a variety of strains, thereby offering more choice to individuals who use marihuana for medical purposes;
    Licensed Producers will have to demonstrate compliance with regulatory requirements such as quality control standards, record-keeping of all activities as well as inventories of marihuana, and physical security measures to protect against potential diversion;
    Licensed Producers will distribute marihuana for medical purposes to the registered client via secure courier;
    storefronts or retail outlets will not be permitted; and,
    for the first time, nurse practitioners will be able to support access to dried marihuana for medical purposes, if permitted within their respective province or territory.

Under the new regulations, licensed producers will have to meet extensive security and quality control requirements. For example, when potential licensed producers apply to Health Canada for a license, they must demonstrate that:

    They employ a quality assurance person with appropriate training, experience and technical knowledge to approve the quality of their dried marihuana;

    Their production site is indoors, and not in a private dwelling. This would reduce the risk of diversion posted by outdoor production and would reduce health and safety risks associated with producing marihuana in a private dwelling;

    The production site includes restricted-access areas, which would include all areas where a licensed activity is conducted with marihuana and cannabis other than marihuana (i.e. lab, production room, etc);

    Access to the production site is controlled at all times and includes 24/7 visual monitoring systems and an intrusion detection system to detect unauthorized access;

    Key personnel hold a valid security clearance, issued by the Minister of Health; and,

    They have provided a written notification of their application, providing details regarding the location of the production site, to the local police force, local fire authority and local government.

Health care practitioners will sign a medical document enabling patients to purchase the appropriate amount for their medical condition from a Licensed Producer approved by Health Canada.

To help health care practitioners, Health Canada has updated and will soon publish the "Information for Health Care Professionals - Cannabis (marihuana, marijuana) and the cannabinoids" on its web site. The document will present a summary of the peer-reviewed scientific and medical literature concerning potential therapeutic uses and harmful effects of cannabis (marihuana) and cannabinoids.

In order to facilitate the transition from the MMAP to the new regime, both will operate concurrently until March 31, 2014. Program participants can continue to produce marihuana for medical purposes, designate someone to produce for them, or purchase it from Health Canada until that date.

Effective October 1, 2013, new applications for personal or designated production licences will no longer be accepted by Health Canada. At any time during the transition period, individuals can move from their current means of accessing marihuana for medical purposes to purchasing it from Licensed Producers under the new regime.

The current program costs Canadian taxpayers millions of dollars each year because the $5/gram charged to program participants who choose to purchase from Health Canada is heavily subsidized. Under the new regime, Licensed Producers will set the price for marihuana for medical purposes. Once the first established Licensed Producers have set a price for dried marihuana, Health Canada will align the price of its supply with the market price so as not to undermine the creation of this new industry.

Transitioning to the New System

The Government of Canada has introduced new regulations that will change the way Canadians access marihuana for medical purposes. The new Marihuana for Medical Purposes Regulations (MMPR) will be published in Canada Gazette, Part II, on June 19, 2013. The current Marihuana Medical Access Regulations (MMAR) will be repealed on March 31, 2014. During this transition period, both regulations will be in force. Below are some key dates during the transition period.

June 19, 2013

    The Application Form to Become a Licensed Producer, Guidance Document for Applications to Become a Licensed Producer, and Security Clearance Application Form for parties interested in applying to become a Licensed Producer of marihuana for medical purposes will be posted to the Health Canada website.
    Additional information such as guidance documents on product quality and security requirements will also be posted to help Licensed Producers comply with the MMPR.

June 19, 2013 - March 31, 2014

    During the transition period, individuals who have the support of their health care practitioner have the choice of:
        Continuing to access dried marihuana through the Marihuana Medical Access Program (MMAP) until March 31, 2014;
        Registering with, and ordering directly from, an available Licensed Producer under the new regime; or,
        Applying under the MMAP and transferring to the new regime by March 31, 2014.

October 1, 2013

    New applications for personal-use and designated-person production licences, and applications to change the location of a production site or the number of plants are no longer accepted by Health Canada. However, Health Canada will continue to renew personal-use and designated-person production licences under the MMAP.
    New applicants to the current program will either have to obtain dried marihuana from Health Canada, or go directly to an approved Licensed Producer.
    Individuals who obtain support from their health care practitioner by means of a medical document under the new system can only obtain their supply of dried marihuana from a Licensed Producer.

March 31, 2014

    The MMAR are repealed and the MMAP ends.
    All Authorizations to Possess (ATP), Personal-Use Production Licenses (PUPL) or Designated-Person Production Licences (DPPL) expire.

April 1, 2014

    Health Canada will no longer sell and distribute marihuana for medical purposes.
    Personal and designated production is no longer permitted. All PUPL or DPPL holders must safely dispose of all dried marihuana and marihuana plants.
    The only legal source to obtain marihuana for medical purposes for Canadians is from Licensed Producers under the new regime.
    ATPs issued under the MMAR cannot be used by an individual as a valid authorization to possess dried marihuana for medical purposes.
    ATPs are valid for registration with a Licensed Producer until the validity date (the latest date specified on the document).

Contact Information

    Media Inquiries:
    Health Canada

    Cailin Rogers
    Office of the Honourable Leona Aglukkaq
    Federal Minister of Health
    (613) 957-0200

    Public Inquiries:


[0] Message Index

[#] Next page

Go to full version